Language Select
Varian Logo

Press Releases

November 13, 2019
Varian (NYSE: VAR) today announced for the third year in a row, it was named one of America's Most JUST Companies in 2019, according to the JUST Capital and Forbes magazine JUST 100 List. Varian... Read more
November 06, 2019
In an effort to elevate the patient voice in cancer care, Varian (NYSE: VAR) announced it has been selected as the vendor of choice by the Michigan Oncology Quality Consortium (MOQC) to support... Read more
October 30, 2019
Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach into New Zealand and Asia, has made a purchase order to further improve the quality of cancer care treatment... Read more
October 29, 2019
Varian (NYSE: VAR) today announced Anshul Maheshwari, vice president and treasurer will take on an expanded role of Investor Relations effective December 1, 2019. All future investor inquiries... Read more
October 24, 2019
Varian (NYSE: VAR) today announced it was selected by The Ohio State University to equip a new multi-room proton therapy center in central Ohio with the ProBeam 360° system. This new proton... Read more
October 23, 2019
In an effort to expand the availability of adaptive radiotherapy to patients at its hospital, Amsterdam UMC has placed an order for six Varian Ethos™ therapy solutions. Ethos therapy is an... Read more
October 23, 2019
Fourth Quarter 2019 Summary Oncology Systems gross orders grew 7% in dollars and 7% in constant currency; North America gross orders grew 10%; 17 Ethos™ orders received in Europe and Australia... Read more
October 23, 2019
Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B.... Read more
October 14, 2019
Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant... Read more
October 08, 2019
Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla. The Varian interventional... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com